Updated:
Is Private Equity
İş Girişim Sermayesi is a Turkish private equity firm making direct investments. In 2025, it established Enlila as a wholly-owned subsidiary to make long-term...
Is Private Equity
İş Girişim Sermayesi is a Turkish private equity firm making direct investments. In 2025, it established Enlila as a wholly-owned subsidiary to make long-term strategic investments in biotechnology, specifically targeting obesity and aging-related chronic diseases through academic research commercialization. The firm also invests in the food sector, including natural meat products and dog treats through its portfolio company Agrinatura.
General information
Firm type
Private Equity
Year founded
2000
Location
Region
Middle East
Country
Turkey
City
Istanbul
Corporate office
Istanbul, Turkey
Sector focus
Frequently asked questions
Does İş Private Equity raise external funds or manage third-party capital?
No. İş Private Equity invests exclusively from the balance sheet of Türkiye İş Bankası. It does not raise blind-pool funds, manage capital for external limited partners, or operate as a fund-of-funds. This permanent-capital model frees the firm from the fundraising cycle and fixed-duration fund structures typical of independent private equity managers.
What types of investments does İş Private Equity typically pursue?
The firm is a generalist private equity investor targeting mid-sized to large Turkish enterprises. Its mandate spans growth capital, expansion-stage investments, and control buyouts, with a preference for significant minority or majority stakes. Sector exposure has historically included financial services, industrials, consumer goods, and healthcare, sourced largely through İş Bankası's extensive commercial banking relationships across Turkey.
How does İş Private Equity source investment opportunities?
The firm's primary sourcing advantage is its integration with Türkiye İş Bankası, which operates one of Turkey's largest corporate banking networks. Loan officers and relationship managers across the bank's branch network provide a proprietary origination channel into privately held Turkish companies that independent private equity firms cannot replicate. The bank's century-long corporate relationships give İş Private Equity early visibility into succession situations, growth-capital needs, and restructuring opportunities.
How does the firm's permanent-capital structure affect its investment behavior?
Without fund-life constraints, İş Private Equity can hold portfolio companies indefinitely. This allows the firm to invest through Turkey's volatile economic cycles without the forced exit pressure that independent managers with 10-year fund lives face. The cost of this patient-capital advantage is that investment pace and exit decisions are subject to the parent bank's broader capital-allocation priorities and regulatory capital requirements, which can shift with banking-sector policy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: